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The ketogenic diet has been in clinical use for over 80 years for the symptomatic
treatment of epilepsy.
1 Although its clinical use declined after the introduction of
antiepileptic drugs, the ketogenic diet has undergone a resurgence and has gained
popularity since it was discovered that it is an effective therapy for intractable
epilepsy, especially in pediatric patients.
2 Many clinical studies have shown its
efficacy,
3 and the ketogenic diet is now widely used around the world.
4 The keto-
genic diet is a high fat, low-carbohydrate diet that induces ketoacidosis, mimick-
ing the metabolic state of starvation. Although its clinical relevance is well
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Purpose: The ketogenic diet has long been used to treat epilepsy, but its mechanism
is not yet clearly understood. To explore the potential mechanism, we analyzed the
changes in gene expression induced by the ketogenic diet in the rat kainic acid (KA)
epilepsy model. Materials and Methods: KA-administered rats were fed the
ketogenic diet or a normal diet for 4 weeks, and microarray analysis was performed
with their brain tissues. The effects of the ketogenic diet on cathepsin E messenger
ribonucleic acid (mRNA) expression were analyzed in KA-administered and normal
saline-administered groups with semi-quantitative and real-time reverse transcription
polymerase chain reaction (RT-PCR). Brain tissues were dissected into 8 regions to
compare differential effects of the ketogenic diet on cathepsin E mRNA expression.
Immunohistochemistry with an anti-cathepsin E antibody was performed on slides
of hippocampus obtained from whole brain paraffin blocks. Results: The microarray
data and subsequent RT-PCR experiments showed that KA increased the mRNA
expression of cathepsin E, known to be related to neuronal cell death, in most brain
areas except the brain stem, and these increases of cathepsin E mRNA expression
were suppressed by the ketogenic diet. The expression of cathepsin E mRNA in the
control group, however, was not significantly affected by the ketogenic diet. The
change in cathepsin E mRNA expression was greatest in the hippocampus. The
protein level of cathepsin E in the hippocampus of KA-administered rat was elevated
in immunohistochemistry and the ketogenic diet suppressed this increase.
Conclusion: Our results showed that KA administration increased cathepsin E
expression in the rat brain and its increase was suppressed by the ketogenic diet. 
Key Words: Cathepsin E, epilepsy, kainic acid, ketogenic diet, neuroprotection
Received: August 4, 2009
Revised: December 3, 2009
Accepted: December 23, 2009
Corresponding author: Dr. Dojun Yoon,
Department of Biochemistry, 
College of Medicine, Kwandong University,
522 Naegok-dong, Gangneung 210-701, Korea.
Tel: 82-33-649-7474, Fax: 82-33-641-1074
E-mail: mozart@kd.ac.kr 
*These authors equally contributed to this
work.
∙The authors have no financial conflicts of
interest.
© Copyright:
Yonsei University College of Medicine 2010
This is an Open Access article distributed under the
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/
licenses/by-nc/3.0) which permits unrestricted non-
commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited.
INTRODUCTIONdocumented, its mechanism remains obscure.
5 To investi-
gate potential molecular mechanisms, we analyzed changes
in gene expression induced by the ketogenic diet in a kai-
nic acid (KA) animal model. KA, an analogue of gluta-
mate, is an excitotoxin that can induce epilepsy in animals
similar to human temporal lobe epilepsy.
6,7 Administration
of KA in the rodent results in neuronal cell death mainly in
the limbic system.
8 The ketogenic diet is known to be effec-
tive in KA-induced epilepsy
9 and to protect neuronal cell
death in the hippocampus of KA-administered mice.
10
Here, we performed a DNA microarray analysis to elucidate
the effect of the ketogenic diet on gene expression in the
KA animal model. In the microarray analysis, several genes
including cathepsin E were down-regulated by the ketogenic
diet in KA-administered rats. Cathepsin E is an intracellular,
nonlysosomal aspartic proteinase that has been associated
with brain ischemia,
11 brain aging,
12 neuronal degenera-
tion,
13 and excitotoxin-induced neuronal cell death.
14 When
KA was injected into the ventricle of rat brain, a marked
elevation in the messenger ribonucleic acid (mRNA) level
of cathepsin E, followed by increases of both matured and
modified cathepsin E proteins was observed in the hippo-
campus,
14 which is known to be an important brain region in
epileptogenesis. Hence, we investigated the correlation be-
tween cathepsin E expression and the ketogenic diet in the
KA animal model.
Diets
The ketogenic diet consisted of 78.85% (w/w) lipid, 9.5%
(w/w) protein, 0.76% (w/w) carbohydrate, 5% (w/w)
cellulose, 3.8% (w/w) mineral mix (AIN-76), and 2.09%
(w/w) vitamin mix (AIN-76A)
15 and was purchased from
Dyets Inc. (Bethlehem, PA, USA). At the beginning of an
experiment, animals were fasted for 24 hours and then
fed the ketogenic diet (ad libitum) or a normal diet (ad
libitum). 
Animals and treatments
Male Sprague-Dawley rats were obtained from SLC Inc.
(Shizuoka, Japan), housed 3 or 4 to a cage, kept in a tem-
perature-controlled room at 22˚C with 12-hour day-night
cycles (lights on at 7 a.m.) , and weighed every week. All
rats were 5 weeks old on arrival and 6 weeks old at the
beginning of the experiment. KA (8 mg/kg) was admi-
nistered i.p. to rats of the experimental group (n = 20), and
saline was administered to rats of the control group (n =
10).
16 The half rats of the experimental and control groups
were fed the ketogenic diet starting 2 days after the injec-
tion, and the other half of each group were fed a normal
diet. The diet continued to be provided for 4 weeks, after
which the animals were sacrificed and the brains were
removed intact or dissected into 8 regions: frontal cortex,
posterior cortex, striatum, hippocampus, thalamus, brain
stem, cerebellum, and hypothalamus, amygdala, septum,
and preoptic area (HASP) to analyze differential exp-
ression of genes in different brain areas.
17 Whole brains (n
= 3 for each group) or brain regions (n = 3 for each group)
were mixed and homogenized for the microarray experi-
ment or reverse transcription polymerase chain reaction
(RT-PCR). For immunohistochemistry experiment, KA
was administered i.p. to rats with different doses of 12
mg/kg (n = 6) or 25 mg/kg (n = 6), and normal saline to con-
trol rats (n = 6). Four out of 6 rats were dead in the higher-
dose group (25 mg/kg) after KA injection, whereas no rat
was dead in the lower-dose group (12 mg/kg). The half of
each group was fed a normal diet or the ketogenic diet for
4 weeks as described above.
Quantification of β β-hydroxybutyrate
Blood samples were obtained from rat tails every week.
Blood levels of β-hydroxybutyrate (β-HBA) were assayed
with a β-HBA kit (Sigma Diagnostics, St Louis, MO,
USA) according to the manufacturer’s protocol. Briefly, 5
µL of serum was mixed with 0.3 mL of β-HBA reagent, a
component of the kit, and the initial absorbance (OD345) was
immediately measured. After the samples were incubated
at 37˚C for 15 minutes with 0.25 U β-HBA dehydrogenase,
their absorbance (OD345) was obtained again. The con-
centration of β-HBA for each sample was calculated from
the difference of these two absorbances by comparison
with standard solutions.
Microarray analysis
The effects of a normal diet and the ketogenic diet on gene
expression in the brains of KA-injected rats were compared
using the microarray technique. Total ribonucleic acid
(RNA)(40 µg) was isolated from homogenized brain tissues
using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and
sent to Digital Genomics Inc. (Seoul, Korea) for microar-
ray analysis. The TwinChip
TM Rat 5K (Digital Genomics),
which has duplicated spots for 4,283 rat genes on each
chip, was used for the microarray analysis. The probe was
labeled with Cy3 for the normal-diet rats and with Cy5 for
the ketogenic-diet rat. The means of the data from each
pair of duplicated spots were used for comparing gene
expression. All microarray data discussed in this publi-
cation have been deposited in NCBIs Gene Expression
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are
accessible through GEO Series accession number GSE
19277 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc
=GSE19277).
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MATERIALS AND METHODSSemi-quantitative and real-time RT-PCR 
Total RNAs (1 µg) isolated from each sample were used
for complementary deoxyribonucleic acid (cDNA) synthesis
with SuperScript II reverse transcriptase (Invitrogen). The
following primers were used to measure the mRNA level
of genes. In the semiquantitative RT-PCR analysis, for
cathepsin E: 5’-ACTGTGATGTTCTGCTCTGAGGGC
TG-3’ (sense) and 5’-GCTGCGTGGCTATTTATCAC
ACCATT-3’ (antisense), for β-actin: 5’-CCCAGAGCAA
GAGAGGCATCCT-3’ (sense) and 5’-ACGCACGATTT
CCCTCTCAGCT-3’ (antisense). In the real-time RT-PCR
analysis, for cathepsin E: 5’-TCAATGAGCCCCTCATC
AACTACC-3’ (sense) and 5’-TGGATGAGCCCGTGTC
AAAGAT-3’ (antisense), for β-actin: 5’-ACCACACTTT
CTACAATGAGCTGCG-3’ (sense) and 5’-TGGGTCAT
CTTTTCACGGTTGG-3’ (antisense). Semiquantitative
PCR amplification was performed for 25 cycles (94˚C for
30 seconds, 63˚C for 30 seconds, and 72˚C for 30 seconds
for cathepsin E; 94˚C for 30 seconds, 55˚C for 30 seconds,
and 72˚C for 30 seconds for β-actin). Real-time PCR
reactions were performed in triplicate and subjected to 45
cycles (94˚C for 15 seconds, 55˚C for 30 seconds, and 72˚C
for 30 seconds) in the presence of 1×SYBR Green mix
(Applied Biosystems, Foster City, CA, USA) using a Rotor-
Gene
TM 3,000 (Corbett Life Science, Mortlake, Sydney,
Australia). The amount of product was determined at the
end of each cycle by the Rotor-Gene software (Corbett Life
Science). The relative amounts of cathepsin E mRNA were
normalized and calculated using the Pfaffl method.
18  
Immunohistochemistry
Rats were anesthetized with ether and transcardially per-
fused with neutral buffered formalin (NBF). Whole brains
were removed and cut into small pieces, washed overnight,
dehydrated, and embedded in paraffin. Embedded brain
tissues were sectioned using a microtome, mounted on
glass slides, and dried. The avidin-biotin complex (ABC)
kit (Vector laboatories, Burlingame, CA, USA) was used to
detect the cathepsin E antigen in the brain tissue as desc-
ribed below. After the removal of the paraffin, the tissue
sections were incubated with proteinase K for 20 minutes
at 37˚C for the purpose of enhancing the reactivity of the
primary antibody followed by quenching endogenous
peroxidase activity with 3% hydrogen peroxide. After
incubation with normal rabbit serum for 1 hour at room
temperature, primary antibody reaction was performed for
36 hours in 4˚C with the antibody against cathepsin E
(Waco Pure Chemical Industries Ltd., Osaka, Japan)
diluted 1 : 100 with phosphat buffer solution (PBS) contain-
ing 1% normal rabbit serum. Subsequent incubation with
biotinylated secondary antibody and the ABC reagent
(Vector laboatories) was performed for 1 hour each at
room temperature. For peroxidase substrate reaction, the
sections were treated with PBS containing 0.05% diamino-
benzidine (DAB) and 0.0015% hydrogen peroxide. The
tissue sections were counterstained with the hematoxylin
solution if it was necessary. The hippocampal areas were
observed and photographed using a BX-50 microscope
and DP70 microphotography (Olympus, Tokyo, Japan).
Statistics
All statistical data are presented as means ± standard error
of measurement. Statistical analyses were performed with
one-way analysis of variance followed by Bonferroni post
hoc test using SPSS version 16 (SPSS Inc., Chicago, IL,
USA). p< 0.05 was considered to be significant. 
Ketogenic diet induces ketoacidosis
Rats were administered KA (8 mg/kg) or normal saline and
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Fig. 1. Changes of body weight and serum β-hydroxybutyrate. (A) Groups fed the ketogenic diet (NS-KD and KA-KD) gained less body weight than the control groups
fed a normal diet (NS-ND and KA-ND). (B) The serum level of β-hydroxybutyrate increased due to the ketogenic diet in NS-KD and KA-KD rats. NS-ND, normal saline,
normal diet; NS-KD, normal saline, ketogenic diet; KA-ND, kainic acid, normal diet; KA-KD, kainic acid, ketogenic diet. 
RESULTS
ABfed a normal diet or the ketogenic diet for 4 weeks. The
groups were designated normal saline, normal diet (NS-
ND), normal saline, ketogenic diet (NS-KD), KA, normal
diet (KA-ND), and KA, ketogenic diet (KA-KD). Re-
gardless of KA injection, rats fed the ketogenic diet gained
less body weight than rats fed a normal diet (Fig. 1A), which
is consistent with previous reports.
19,20 The ketogenic diet
induced ketoacidosis in the NS-KD and KA-KD groups
(Fig. 1B): the concentrations of β-HBA increased from
basal levels (< 0.1 mM) to 0.69 ± 0.13 mM (NS-KD rats)
and to 1.59 ± 0.17 mM (KA-KD rats) in the first week,
whereas the normal diet did not affect the β-HBA concen-
tration (0.03 ± 0.01 mM, NS-ND rats; 0.08 ± 0.02 mM,
KA-ND rats). The β-HBA concentration exceeded 2 mM
in the second week and increased further over time in KA-
KD rats, whereas it remained around 1 mM in NS-KD
rats, which is the concentration usually achieved by the
ketogenic diet in the normal rats.
21 
Cathepsin E mRNA expression is downregulated by 
the ketogenic diet
To analyze the changes in gene expression induced by the
ketogenic diet in KA-treated rats, total RNA was isolated
from the whole brains of KA-ND and KA-KD rats and
subjected to a microarray analysis. The mRNA expres-
sions of kinesin family member 5B (Kif5b), cathepsin E,
beta1 subunit of adenosine monophosphate (AMP)-acti-
vated protein kinase (Prkab1), apolipoprotein B editing
protein (Apobec1), and general transcription factor IIa 2
(Gtf2a2) were more than 2 times lower in the ketogenic-
diet group than in the normal-diet group (Table 1). In con-
trast, we did not observe an increase higher than 2-fold in
the expression of any gene in the KA-KD group compared
to the KA-ND group. Of the down-regulated genes, only
cathepsin E is known to be related to epilepsy and this
correlation between cathepsin E and KA prompted us to
confirm the microarray data further with an RT-PCR anal-
ysis. In accordance with the results of the microarray anal-
ysis, cathepsin E mRNA expression was lower in the KA-
KD rats than in the KA-ND rats in a semiquantitative RT-
PCR analysis (Fig. 2).
Ketogenic diet affects KA-induced cathepsin E mRNA
expression, but not normal expression
We compared the effects of the ketogenic diet between
groups administered KA and normal saline to determine
whether the ketogenic diet also affects cathepsin E expres-
sion in the normal rat brain. We also analyzed its differential
effect on local brain regions. When the rats were not admi-
nistered KA, the ketogenic diet did not significantly change
cathepsin E mRNA expression (Fig. 3). Although its
expressions in the frontal cortex, striatum, and thalamus of
NS-KD rats were changed by the ketogenic diet in semi-
quantitive RT-PCR analysis, there was no statistically
significant difference between NS-ND and NS-KD rats in
those areas in real-time RT-PCR. Cathepsin E mRNA ex-
pression, however, was significantly increased in most
brain areas (p < 0.05), except for the brain stem, when KA
was administered to rats fed a normal diet, and all of these
increases in cathepsin E mRNA expression were signifi-
cantly suppressed by the ketogenic diet (p < 0.05) in KA-
KD rats. These results suggest that the ketogenic diet affects
cathepsin E mRNA expression only when it is abnormally
increased by KA. The hippocampus showed the greatest
increase in KA-induced cathepsin E mRNA expression (a
5.8-fold increase), and the ketogenic diet decreased its
expression in KA-KD rats to 50% of the level of KA-ND
rats. However, the cathepsin E mRNA expression in the
hippocampus of KA-KD rats still remained high compared
to NS-ND or NS-KD rats, although there was no signi-
ficant difference between KA-KD and NS-ND rats (p =
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Table 1.Genes with Decreased Expression in Response to the Ketogenic Diet in a Microarray Analysis
Gene name Ratio (KA-KD / KA-ND) GenBank accession no.
Kinesin family member 5B (Kif5b) 0.27 AA924572
Cathepsin E (Ctse) 0.44 AA923919
Protein kinase, AMP-activated, 
0.44 AA924247
beta 1 non-catalytic subunit (Prkab1)
Apolipoprotein B editing protein (Apobec1) 0.45 AA964261
General transcription factor IIa, 2 (Gtf2a2) 0.48 AA924402
KA-KD, kainic acid, ketogenic diet; KA-ND, kainic acid, normal diet.
Fig. 2. Semiquantitative RT-PCR analysis of cathepsin E mRNA expression in
whole brain tissue. Cathepsin E expression was lower in the KA-KD group than
in the KA-ND group. RT-PCR, reverse transcription polymerase chain reaction;
mRNA, messenger ribonucleic acid; KA-KD, kainic acid, ketogenic diet; KA-ND,
kainic acid, normal diet.
Cathepsin E
Kainic acid
Ketogenic diet
β-actin0.054) or NS-KD rat (p = 0.15). In contrast, the level of
cathepsin E mRNA expression in the thalamus of KA-KD
rats was significantly higher than that of NS-ND (p =
0.007) or NS-KD rats (p= 0.039). 
KA-induced cathepsin E protein expression was 
suppressed by the ketogenic diet in the hippocampus
We performed immunohistochemical staining to confirm
the difference of the cathepsin E expression in the neurons
of the rat hippocampal region. KA was administered i.p. to
rats with two different doses (12 mg/kg or 25 mg/kg) to
evaluate the dose-dependent effect of KA on cathepsin E
expression. In normal saline-injected rats (NS-ND and NS-
KD), neurons positive to cathepsin E protein were barely
detected in the cornu ammonis (CA) 3 region of the hippo-
campus (Fig. 4A and B). In the lower-dose (12 mg/kg) KA-
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Fig. 3. Cathepsin E mRNA expression in different brain areas. Rat brains were dissected into 8 compartments. (A) In the semiquantitative RT-PCR analysis, the
ketogenic diet down-regulated cathepsin E expression in the rats given KA, but not in those given normal saline. (B) In the real-time RT-PCR, KA increased cathepsin E
expression in all brain areas examined except the brain stem, and the ketogenic diet suppressed the KA-induced cathepsin E expression. The hippocampus showed
the most prominent change in cathepsin E expression. Data represent the relative amount of cathepsin E mRNA of each group compared to NS-ND in the same brain
area.  *indicates statistical significance (*p< 0.05, **p< 0.01). HASP, hypothalamus, amygdala, septum, and preoptic area. mRNA, messenger ribonucleic acid; RT-
PCR, reverse transcription polymerase chain reaction; NS-ND, normal saline, normal diet; NS-KD, normal saline, ketogenic diet; KA-ND, kainic acid, normal diet; KA-
KD, kainic acid, ketogenic diet.
A
B
Cathepsin E
Frontal cortex
Posterior cortex
Striatum 
Hippocampus
Thalamus
Brain stem
Cerebellum
HASP
Kainic acid
Ketogenic diet
β-actin Cathepsin E β-actinND rat, a small number of neurons in the stratum oriens of
the CA3 region expressed cathepsin E (Fig. 4C). The cath-
epsin E immunoreactive neurons were also observed in the
same region of the lower-dose KA-KD rat in a more or less
sparse manner (Fig. 4D). In the higher-dose (25 mg/kg)
KA-ND rat, a great number of cathepsin E immunoreactive
neurons were observed in the stratum oriens of the CA3
region as well as the CA1 and the CA2 regions (Fig. 4E).
With higher magnifications, most of these neurons appeared
to be pyramidal neurons, the major output neurons of the
hippocampus, although the widespread strong immuno-
reactivity against cathepsin E throughout the perikaryon of
these neurons obscured the detailed morphologies of the
nuclei. The increases in the intercellular spaces and the
pyknotic changes of neurons were observed (Fig. 4G). In
the CA3 region of the higher-dose KA-KD rat, however, the
number of cathepsin E-immunoreactive neurons was dra-
matically decreased by the ketogenic diet and few of them
showed immunoreactivity against cathepsin E as strongly
as those observed in the higher-dose KA-ND rat (Fig. 4F).
These neurons had large, round, euchromatic nuclei, the
characteristics of an intact pyramidal neuron (Fig. 4H). 
Cathepsin E, an aspartic proteinase, is mainly present in
cells of the immune system such as macrophages, lympho-
cytes, microglia, and dendritic cells. Its physiological role
is not yet clearly understood, although it has been proposed
to be involved in the immune response because cathepsin
E-deficient mice show increased susceptibility to bacterial
infections.
22 Abnormally elevated levels of cathepsin E have
been observed in several tumor types, such as pancreatic
ductal adenocarcinoma, cervical adenocarcinoma, gastric
cancer, and lung cancer.
22 Increased cathepsin E expres-
sion has also been observed in aged brains,
12 senile plaques
of Alzheimer’s disease,
23 and KA-injected rat brains.
14 Our
results show that cathepsin E expression increased in the rat
brain when KA was administered, and this KA-induced
cathepsin E expression was suppressed by the ketogenic
diet. To our knowledge, this is the first report that suggests a
direct correlation between the ketogenic diet and cathepsin E. 
The ketogenic diet is now widely used for the treatment
of intractable epilepsy. There is increasing evidence that
the ketogenic diet can provide symptomatic and disease-
modifying activity in a broad range of neurodegenerative
disorders, such as Alzheimer’s disease and Parkinson’s
disease.
24 It is postulated that ketone bodies confer protection
on neurons against diverse types of cell injury.
24 Moreover,
neuroprotection is now considered to be an important me-
chanism for the disease-modifying activity of antiepileptic
drugs.
25,26 Apoptosis is closely related to the neuronal cell
death induced by excitotoxins, and proapoptotic events
such as activation of bcl-2 family members and DNA lad-
dering occur in status epilepticus-induced neuronal cell
death.
27 The suppression of apoptosis has been suggested
as a mechanism for the neuroprotective effect of the keto-
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DISCUSSION
ABCD
EFGH
Fig. 4.Immunohistochemistry of cathepsin E in rat hippocampus. After i.p. administration of normal saline (A and B) or KA (12 mg/kg in C and D, 25 mg/kg in D, E, G and
H), rats were fed a normal diet (A, C, E and G) or the ketogenic diet (B, D, F and H). The CA3 region of the rat hippocampus of the NS-ND (A) and the NS-KD (B) equally
showed very few cathepsin-E positive neurons. In the lower-dose KA-ND rat (C), a small number of neurons expressed cathepsin E, while those of the lower-dose KA-
KD rat (D) distributed more sparsely. In the CA3 region of the higher-dose KA-ND rat (E), widespread expression of cathepsin E by neurons were observed, in contrast
to a marked decrease in the cathepsin E immunoreactivity in the same area of the higher-dose KA-KD rat (F). Details of higher-dose KA-ND neurons exhibit pyknotic
changes (G, arrowheads), whereas neurons of the higher-dose KA-KD rat had round, euchromatic nuclei (H, arrowheads). A, B, G, and H were counterstained  (scale
bar = 500 µm in A, 100 µm in G; A through F are in a same degree of magnification, so are G and H). KA, kainic acid; NS-ND, NS-ND, normal saline, normal diet; NS-KD,
normal saline, ketogenic diet; KA-KD, kainic acid, ketogenic diet; CA3, cornu ammonis.genic diet.
28,29 In addition, cathepsin E is known to be
involved in the apoptosis of erythrocytes
30 and prostate
carcinoma cells.
31 Moreover, KA induced the widespread
pyknosis of CA3 neurons in the hippocampus of KA-ND
rats and pyramidal neurons were mostly preserved by the
ketogenic diet in the hippocampus of KA-KD rats. It seems
reasonable to assume that the suppressive effect of the
ketogenic diet on cathepsin E expression may contribute
its protective role of the neuron by inhibiting apoptosis.
However, no direct evidence of the involvement of cathep-
sin E in neuronal apoptosis has been yet observed.
It is hard to speculate how the ketogenic diet regulates
the transcription of cathepsin E, because little is known
about the signaling pathway involved in the increase of
cathepsin E expression in the KA-animal model. However,
our data imply that the ketogenic diet may suppress cath-
epsin E expression indirectly, because only KA-induced
cathepsin E was suppressed by the ketogenic diet but its
basal expression in control rats (NS-ND and NS-KD) was
not changed by the ketogenic diet. Recently, several genes
were shown to have a pattern of gene expression similar to
that of cathepsin E. Clusterin is a proapoptotic protein that
accumulates in the rat brain following treatment with KA,
and this KA-induced clusterin expression is suppressed by
the ketogenic diet.
32 Proenkephalin, which contributes to the
development of seizures, is induced by KA and down-
regulated by the ketogenic diet through the suppression of
the JNK signaling pathway.
33 These findings including our
data suggest that the transcriptional regulation of many
molecules induced by excitotoxin may be important for the
neuroprotective effect of the ketogenic diet in KA-animal
model.
In conclusion, our results showed that cathepsin E exp-
ressions induced by KA were suppressed by the ketogenic
diet in the rat brain, suggesting that the suppressive effect
of the ketogenic diet on cathepsin E expression might
contribute to the neuroprotective role of the ketogenic diet
in KA-animal model. 
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